From September 2001 to March 2002, Guillermo participated in an exchange programme, temporarily joining the New York office of the US firm Skadden, Arps, Slate, Meagher & Flom. He joined the firm in 1997 and was made partner in 2008. Guillermo San Pedro is a lawyer in the Corporate and Commercial Practice Area of Uría Menéndez’s Madrid office. I Insurance and Reinsurance, M&A, Company Law and Corporate Governance. See PDF of this story.+34 91 586 07 41 View profile Work Department This story closes our coverage of the 10th International Conference on Alzheimer’s Disease and Related Disorders, held last July in Madrid. Madrid: Beyond Aβ-Learning, Age, DNA Damage, and Pai-1 See also Intro/Part 1 and Part 2 of this clinical trials update. Madrid: Highs and Lows of The Insulin Connection See also Intro/Part 1 and Part 3 of this clinical trials update. Madrid: Pooled Antibody Cocktail, New Metal Quencher See also Part 2 and Part 3 of this report. Madrid: Clinical Trials Update-Where Do Things Stand? The 10th International Conference on Alzheimer’s Disease and Related Disorders, held earlier this month in Madrid, offered its share of data on. Madrid: γ-secretase Dimers, A New Model, A Drug in Clinic
Madrid: News from the Vaccine Front-Bloody Complicated? Madrid: News from the Vaccine Front-Phase 1 Hopefuls Madrid: News from the Vaccine Front-Phase 2 Postmortem, Part 1 Madrid: Stressed Brain-SNP Carriers Can Have Cake and Eat Itįamous as they are for their powerful effects throughout the body, circulating stress hormones such as the glucocorticoid cortisol still pose somewhat of a riddle when it comes to.
Madrid: Why Do People Drop Out of Trials?ĭesigning AD trials well would seem to be challenge enough for clinicians in the Alzheimer disease field. Madrid: BACE Found to Have Big Job in Wrapping Motoneuronsīy the wholly unscientific survey of a roving reporter, the single most convincing and surprising molecular biology story that stuck in the minds of scientists at the 10th ICAD meeting was. The 10th International Conference on Alzheimer’s Disease and Related Disorders, ICAD for short, ended yesterday just outside the palatial capital of Spain.
0 kommentar(er)
